<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05062655</url>
  </required_header>
  <id_info>
    <org_study_id>CHM-2021/S21/09</org_study_id>
    <nct_id>NCT05062655</nct_id>
  </id_info>
  <brief_title>Interest of Drug Reconciliation to Ensure the Continuity of the Treatment at Discharge</brief_title>
  <acronym>ICOCON</acronym>
  <official_title>Nterest of Drug Reconciliation to Ensure the Continuity of the Treatment at Discharge</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier le Mans</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier le Mans</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      From a regulatory point of view, medication reconciliation is a necessary process to ensure&#xD;
      safe medication management for patients. According to national studies and the international&#xD;
      scientific literature, the information received by patients and health professionals at&#xD;
      discharge from hospital is insufficient.&#xD;
&#xD;
      Medication reconciliation at discharge reduces medication errors and rehospitalisation, but&#xD;
      few studies have been conducted on the impact of a coordinated and reliable care pathway on&#xD;
      medication continuity.&#xD;
&#xD;
      The iCoCon study will enable a new healthcare organisation to be set up in order to improve&#xD;
      the quality of the patient pathway and the patient's medication management.&#xD;
&#xD;
      This new organisation is part of the policy of continuous improvement of the quality and&#xD;
      safety of care&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 3, 2021</start_date>
  <completion_date type="Anticipated">December 8, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 8, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Demonstrate the value of a coordinated and reliable pathway when patients are discharged from the institution via drug reconciliation to ensure the continuity of patients' treatment</measure>
    <time_frame>1 month after inclusion</time_frame>
    <description>the value of coordinated pathway is evaluate by number of days of treatment interruption between patient discharge and provision of treatment to the patient</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Hospitalized Patient</condition>
  <arm_group>
    <arm_group_label>Drug reconciliation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Drug reconciliation and transmission to pharmacist</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Drug reconciliation</intervention_name>
    <description>Drug reconciliation information transmission to pharmacist interview with the patient</description>
    <arm_group_label>Drug reconciliation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  hospitalized patient&#xD;
&#xD;
          -  Patient with a drug treatment with a particular mode of supply&#xD;
&#xD;
          -  Paediatric patient or an adult patient.&#xD;
&#xD;
          -  First inpatient stay over the inclusion period from late 2021 to late 2022&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient under curatorship or guardianship&#xD;
&#xD;
          -  Patient residing abroad&#xD;
&#xD;
          -  No free, informed and written consent obtained&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christelle JADEAU</last_name>
    <phone>02 44 71 07 81</phone>
    <email>cjadeau@ch-lemans.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier Du Mans</name>
      <address>
        <city>Le Mans</city>
        <zip>72000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christelle JADEAU</last_name>
      <phone>02 44 71 07 81</phone>
      <email>cjadeau@ch-lemans.fr</email>
    </contact>
    <investigator>
      <last_name>Elsa JOUHANNEAU, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 21, 2021</study_first_submitted>
  <study_first_submitted_qc>September 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 30, 2021</study_first_posted>
  <last_update_submitted>September 21, 2021</last_update_submitted>
  <last_update_submitted_qc>September 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Medication reconciliation</keyword>
  <keyword>Continuity</keyword>
  <keyword>Town-hospital network</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

